Department of Health Economics, China Pharmaceutical University, Nanjing, China.
Department of Clinical Pharmacy and Translational Science, University of Tennessee Health Science Center, Memphis, USA.
Health Qual Life Outcomes. 2021 Feb 5;19(1):45. doi: 10.1186/s12955-021-01677-0.
OBJECTIVE: This study aimed to conduct a systematic review and meta-analysis to compare differences in health utilities (HUs) assessed by self and proxy respondents in children, as well as to evaluate the effects of health conditions, valuation methods, and proxy types on the differences. METHODS: Eligible studies published in PubMed, Embase, Web of Science, and Cochrane Library up to December 2019 were identified according to PRISMA guidelines. Meta-analyses were performed to calculate the weighted mean differences (WMDs) in HUs between proxy- versus self-reports. Mixed-effects meta-regressions were applied to explore differences in WMDs among each health condition, valuation method and proxy type. RESULTS: A total of 30 studies were finally included, comprising 211 pairs of HUs assessed by 15,294 children and 16,103 proxies. This study identified 34 health conditions, 10 valuation methods, and 3 proxy types. In general, proxy-reported HUs were significantly different from those assessed by children themselves, while the direction and magnitude of these differences were inconsistent regarding health conditions, valuation methods, and proxy types. Meta-regression demonstrated that WMDs were significantly different in patients with ear diseases relative to the general population; in those measured by EQ-5D, Health utility index 2 (HUI2), and Pediatric asthma health outcome measure relative to Visual analogue scale method; while were not significantly different in individuals adopting clinician-proxy and caregiver-proxy relative to parent-proxy. CONCLUSION: Divergence existed in HUs between self and proxy-reports. Our findings highlight the importance of selecting appropriate self and/or proxy-reported HUs in health-related quality of life measurement and economic evaluations.
目的:本研究旨在进行系统评价和荟萃分析,比较儿童自我报告和代理报告的健康效用(HU)差异,并评估健康状况、评估方法和代理类型对差异的影响。
方法:根据 PRISMA 指南,检索 PubMed、Embase、Web of Science 和 Cochrane Library 截至 2019 年 12 月发表的符合条件的研究。采用混合效应荟萃回归分析,以探索每种健康状况、评估方法和代理类型之间 WMD 的差异。
结果:最终纳入 30 项研究,共纳入 15294 名儿童和 16103 名代理自我报告的 211 对 HU。本研究共涉及 34 种健康状况、10 种评估方法和 3 种代理类型。总体而言,代理报告的 HU 与儿童自身评估的 HU 存在显著差异,但这些差异在健康状况、评估方法和代理类型方面的方向和大小不一致。元回归分析表明,与一般人群相比,在耳部疾病患者中,WMD 差异显著;与视觉模拟量表法相比,在 EQ-5D、健康效用指数 2(HUI2)和儿科哮喘健康结局测量中,WMD 差异显著;而在采用临床医生-代理和照顾者-代理与父母-代理相比,WMD 差异不显著。
结论:自我报告和代理报告的 HU 存在差异。我们的研究结果强调了在健康相关生活质量测量和经济评估中选择合适的自我和/或代理报告 HU 的重要性。
Health Qual Life Outcomes. 2021-2-5
Med Decis Making. 2017-10-7
Cochrane Database Syst Rev. 2022-2-1
JMIR Public Health Surveill. 2023-10-31
Health Qual Life Outcomes. 2024-5-31
Cochrane Database Syst Rev. 2019-10-3
Arch Argent Pediatr. 2017-12-1
Med Decis Making. 2017-10-7